Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per sponsor: Bayer
Woman and Man
Between 18 years
and 99 years
Bayer
Update Il y a 5 ans
Étude BAY 16443 : étude de phase 1, en escalade de dose, évaluant la tolérance du BAY 1163877, un inhibiteur de FGFR, chez des patients ayant une tumeur solide réfractaire localement avancée ou métastatique. [essai clos aux inclusions]
BAY 16443 : Etude de phase I, ouverte, non-randomisée, d'escalade de dose, destinée à évaluer l'innocuité, la tolérance, les pharmacocinétiques et la dose maximale tolérée de BAY 1163877 chez des pati...
Country
France
organs
Tumeurs solides
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Bayer AG
Update Il y a 5 ans
A study to test the safety and effectiveness of Bay 41-6551 as additional therapy to standard of care antimicrobial treatment in patients who have Gram-Negative Pneumonia and are intubated and mechanially ventilated
To demonstrate that as adjunctive therapy to IV antibiotics, BAY 41-6551 400 mg (amikacin as free base) administered as an aerosol by the PDDS Clinical every 12 hours is safe and more effective than p...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer AG
Update Il y a 5 ans
Efficacy and safety of riociguat in patients with high blood pressure in the blood vessels of the lungs associated with interstitial pneumonias of unknown cause
To evaluate the efficacy and safety of 26-weeks of treatment with riociguat vs. placebo in patients with symptomatic PH associated with IIP
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 5 ans
A clinical trial to compare the safety of moxifloxacin given as infusion in the vein and as tablet to the safety of another treatment regimen in patients with a complicated infection of the abdominal cavity
To evaluate the safety of treatment with moxifloxacin (compared to the safety of IV ertapenem followed by PO amoxicillin/clavulanate)
Country
None
organs
None
Specialty
None
More information
Woman Max 99 years
Bayer HealthCare AG
Update Il y a 5 ans
A multi-center, double-blind, double-dummy, randomized, controlled, parallel-group study to assess efficacy and safety of SH T00658ID compared to SH D593B in the treatment of primary dysmenorrhea
The primary objective of this study is to show superiority of SH T00658ID over SH D593B with respect to the number of days with dysmenorrheic pain in a defined period, i.e. comparison between two bas...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 5 ans
Randomized phase II study of roniciclib vs placebo in subjects receiving chemotherapy for SCLC Roniciclib és placebo randomizált, II. fázisú vizsgálata kissejtes tüdőrákban szenvedő, kemoterápiával kezelt betegeknél
The primary objective is to compare roniciclib with placebo in addition to background treatment with chemotherapy (either cisplatin + etoposide or carboplatin + etoposide) in terms of progression free...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer Consumer Care AG
Update Il y a 5 ans
A randomized, , double-blind, single centre, intra-individual comparison study with repeated application to assess the wound-healing efficacy of a 5 % Dexpanthenol ointment compared with placebo in patients with superficial, abrasive wounds
Re-epithelization day 5
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 5 ans
Long-term study to collect additional information to evaluate the saftey and tolerability of BAY 63-2521 in different doses
To investigate the safety, tolerability, and feasibility of individual titration of BAY 63 2521 according to peripheral systolic blood pressure. In addition, long term safety and tolerability of BAY ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 5 ans
A randomized controlled study of BAY 43-9006 in combination with doxorubicin versus doxorubicin in patients with advanced hepatocellular carcinoma
The primary objective is to evaluate the effect of doxorubicin plus sorafenib or doxorubicin plus placebo on time to progression (TTP) in patients with advanced hepatocellular carcinoma
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Bayer Healthcare AG, D-51368 Leverkusen, Germany
Update Il y a 5 ans
Pivotal phase III trial to investigate the efficacy and safety of an Orodispersible Tablet vardenafil versus placebo in the treatment of men with Erectile dysfunction (ED) - a fixed-dose, double-blind, raNdomized multi-center Trial - POTENT I
The primary objective of this study is to compare the efficacy and safety of vardenafil ODT 10 mg (PRN) after 12 weeks of treatment or LOCF with placebo in a general population of men with erectile dy...
Country
None
organs
None
Specialty
None
Closed trial
More information
1
2
3
4
5
6
7
8
9
10
Next